DBVT DBV Technologies S.A.

33.08
+1  (2%)
Previous Close 32.40
Open 32.94
Price To book 6.18
Market Cap 1.52B
Shares 46,000,000
Volume 58,401
Short Ratio 3.58
Av. Daily Volume 74,679

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 completion of enrollment announced March 10, 2017. Data due 2H 2017.
Viaskin Peanut (REALISE)
Peanut allergy
Phase 1/2 data due 2H 2017.
Viaskin Milk
Cow’s milk protein allergy (CMPA)
Phase 3 completion of enrollment announced March 10, 2017. Data due 2H 2017.
Viaskin Peanut (PEPITES)
Peanut allergy

Latest News

  1. DBV Technologies : Monthly information regarding the total number of voting rights and total number of shares of the Company
  2. DBV Technologies to Attend the 10th Kempen Life Sciences Conference
  3. DBV Technologies, BioNet-Asia and Geneva University Hospitals Announce Phase I Trial Results of Viaskin rPT in Pertussis Booster Vaccination
  4. DBV Technologies : Announces Filing of its 2016 "Document de Référence" and Annual Report on Form 20-F
  5. DBV Technologies Reports Full Year 2016 Financial Results
  6. DBV Technologies Announces Completion of Enrollment of the REALISE Study in Peanut Allergic Children
  7. 7 Stocks Trending Up With Monster Volume
  8. DBV Technologies :Data at AAAAI 2017 Show Lasting Response and Favorable Safety Profile of Investigational Agent, Viaskin Peanut, Throughout Three Years of Treatment of Peanut Allergic Children
  9. A patch could fix your peanut-allergy problem
  10. DBV Technologies to Attend Upcoming Investor Conferences
  11. DBV Technologies Reports December 31, 2016 Cash Position
  12. DBV to Present Data at the 2017 AAAAI Meeting Highlighting the Therapeutic Potential of EPIT®
  13. DBV Technologies Announces Completion of Enrollment of Phase IIA Study of Viaskin Milk for the Treatment of Pediatric Eosinophilic Esophagitis
  14. DBV Technologies to Present at the LEERINK Partners 6th Annual Global Healthcare Conference
  15. DBV Technologies Announces Financial Calendar 2017
  16. DBV Technologies presents its Half-year Statement of the Liquidity Contract
  17. Is DBV Technologies (DBVT) Stock a Solid Choice Right Now?